Portfolio company
Gibran
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops adaptive artificial intelligence research platforms to augment human creativity and scientific discovery for researchers, educators and drug discovery teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Kiin Bio
This company develops an artificial intelligence platform of virtual scientists to automate and coordinate drug discovery workflows for biotechnology firms and academic researchers.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Relation
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners and its own pipeline of medicines.
Azulene Labs
The company develops a computational chemistry platform and physics-based machine learning models for drug discovery and materials science researchers.
Revanta
Revanta develops an artificial intelligence platform for drug design to support biotechnology companies.
Genspark
The company develops an artificial intelligence platform for creating documents, visuals, code, and dashboards for business users and creators.
Cheiron
This company develops an AI-driven operating system and knowledge graph to streamline drug development processes for biopharmaceutical firms and life sciences researchers.
